Gavitt A Woodard

8PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersAutoimmunityMolecular targetsSolid tumoursRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 19, 2025
Is Major Pathologic Response the Best Surrogate End Point for Neoadjuvant Trials?

Gavitt A Woodard, Brendon M Stiles

|Dec 03, 2025
Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor-CD74 signaling.

Sang-Hun Kim, Jessica Nouws, Jannik Ruwisch

|Jan 20, 2025
The evolving landscape of adjuvant therapy in T1-T2N0 resected non-small cell lung cancer: a narrative review.

Emily June Zolfaghari, Andrew Dhanasopon, Gavitt A Woodard

|Dec 19, 2024
Sex-based differences in CEACAM5 expression in lung cancer.

Gavitt A Woodard, Emma R Kane, Nicholas Todorovic

|Oct 30, 2023
Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?

Gavitt A Woodard, Christina Cho, Lieping Chen

|Mar 17, 2021
Resectability, Recurrence, and Risk Stratification of Giant Solitary Fibrous Tumors in the Thoracic Cavity.

Gavitt A Woodard, Daffolyn Rachael Fels Elliott, Ava Yap

Pageof 2

Frequent Collaborators

1 joint publications

Sang-Hun Kim

1 joint publications

Jessica Nouws

1 joint publications

Jannik Ruwisch

1 joint publications

Johad Khoury